 |
|
|
| |
Positive Results from REGENERATE: A Phase 3 International, Randomized, Placebo-Controlled
Study Evaluating Obeticholic Acid Treatment for NASH
|
| |
| |
EASL 2019 April 10-14 Vienna
Zobair Younossi1, Vlad Ratziu2, Rohit Loomba3, Mary Rinella4, Quentin M. Anstee5, Zachary
Goodman1, Pierre Bedossa6, Andreas Geier7, Susanne Beckebaum8, Philip Newsome9, David
Sheridan10, James Trotter11, Whitfield Knapple12, Eric Lawitz13, Kris Kowdley14, Aldo Montano-Loza15,
Jerome Boursier16, Philippe Mathurin17, Elisabetta Bugianesi18, Guiseppe Mazzella19, Antonio Olveira20,
Helena Cortez-Pinto21, Isabel Graupera22, David Orr23, Lise Lotte Gluud24, Jean-Francois Dufour25,
David Shapiro26, Jason Campagna26, Luna Zaru26, Leigh MacConell26, Reshma Shringarpure26,
Stephen Harrison27, Arun Sanyal28 on behalf of the REGENERATE Study Investigators
|
| |
|
|
|
|
|
